Yeeha! Games Partners with SOMSOC GALLERY to Bridge Web2 and Web3 through Designer Toy Art
September 21, 2024 08:33 ET
|
Yeeha Games
SINGAPORE, Sept. 21, 2024 (GLOBE NEWSWIRE) -- Yeeha! Games, an industry-leading gaming platform, announced an exciting strategic partnership with Tokyo-based SOMSOC GALLERY during the Token2049...
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
September 20, 2024 11:59 ET
|
Trxade Health, Inc.
TAMPA, FL and COMMACK, NY, Sept. 20, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC (“Scienture”), a wholly owned subsidiary of TRxADE, today announced...
Le médicament Iqirvo® (élafibranor) d’Ipsen est approuvé dans l’Union européenne comme premier nouveau traitement contre la cholangite biliaire primitive depuis près d’une décennie
September 20, 2024 08:57 ET
|
Ipsen Pharma
La Commission européenne accorde une autorisation de mise sur le marché conditionnelle à Iqirvo® (élafibranor), nouveau traitement premier de sa classe thérapeutique contre la cholangite biliaire...
Ipsen’s Iqirvo® (elafibranor) approved in the European Union as first new treatment for primary biliary cholangitis in nearly a decade
September 20, 2024 08:57 ET
|
Ipsen Pharma
European Commission grants conditional marketing authorization for Iqirvo® (elafibranor), first-in-class new treatment for primary biliary cholangitis (PBC), a rare liver diseaseApproval follows...
Positive phase III results show Xofluza significantly reduces the transmission of influenza viruses
September 19, 2024 01:00 ET
|
F. Hoffmann-La Roche Ltd
Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from an infected person to household membersThis is the first time that any antiviral used in the treatment...
Ipsos : Investissement du fonds Lac1
September 17, 2024 01:50 ET
|
IPSOS
Investissement du fonds Lac1 Paris, 17 septembre 2024 – Le Conseil d’administration d’Ipsos considère que la décision du fonds Lac1 de devenir un actionnaire important et de long terme de la...
Ipsos: Investment of the Lac1 fund
September 17, 2024 01:50 ET
|
IPSOS
Investment of the Lac1 fund Paris, 17 September 2024 – The Board of Directors of Ipsos welcomes the decision of the Lac1 fund to become a major long-term shareholder in the company. The...
Global Zirconia Based Dental Ceramics Market is Expected to Grow at a CAGR of 9.1% over the Forecast Period (2024 – 2034): A Report by TNR, The Niche Research
September 16, 2024 15:32 ET
|
The Niche Research
Wilmington, Delaware, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Zirconia based dental ceramics are advanced materials used in dentistry, primarily composed of zirconium dioxide (ZrO₂). These ceramics are...
Les résultats finaux de l’essai de Phase III CABINET corroborent les bénéfices en termes d’efficacité de Cabometyx® dans les tumeurs neuroendocrines avancées
September 16, 2024 08:45 ET
|
Ipsen Pharma
Les données ont démontré une réduction significative, tant sur le plan statistique que sur le plan clinique, du risque de progression de la maladie ou de décès avec Cabometyx® (cabozantinib) par...
Final results from CABINET Phase III trial reinforce efficacy benefits of Cabometyx® in advanced neuroendocrine tumors
September 16, 2024 08:45 ET
|
Ipsen Pharma
Data demonstrated statistically significant and clinically meaningful reduction in risk of disease progression or death with Cabometyx® (cabozantinib) versus placebo in advanced pancreatic and...